Report Overview

In a market currently valued at US$36 billion, pharmacotherapies for conditions such as sleep disorders, addictions, depression, infertility, sexual disorders, and chronological ageing, are forecast to triple in value to over US$100 billion by 2020. Spectra`s data-intensive study, Antiageing and Life Enhancement Pharmacotherapeutics: Rejuvenating Drug Markets to 2012 and Beyond, predicts dramatic expansion based on increasing ageing populations, high unmet needs related to ageing and lifestyle dissatisfaction, unrelenting media fixation on youthfulness and image, and pharmacological innovation. With more than 90 marketed products evaluated and over 270 candidates identified in clinical development, this unique 580-page comprehensive multipart report, covering over 15 major therapy areas, provides unrivalled analysis of the enlarging dynamic market, and illustrates high-growth market sectors and prospects that may be positioned for market dominance on commercialization.

Combining extensive research methodology with analytical and strategic review, the study offers a unique insight to the scope of the product market and development pipeline and shows, for example, how ethical drugs are increasingly being used in a therapeutic switch capacity to target cosmetic antiageing and life enhancement. Furthermore, drugs in development in the field are shown to be highly sophisticated products with multiple therapeutic benefits which may revolutionize medical treatments across a number of therapy areas.

Contents of this report are also expanded upon and available by separate reports in the Spectra Compendia series